Ocular Therapeutix, Inc. (OCUL)

Ocular Therapeutix Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	-	-	195.81	102.3	164.16
Cash & Short-Term Investments	-	-	195.81	102.3	164.16
Cash Growth	-	-	91.41%	-37.68%	-28.02%
Accounts Receivable	30.65	32.39	26.18	21.33	21.14
Inventory	3.56	3.04	2.31	1.97	1.25
Other Current Assets	10.86	13.46	7.94	4.03	4.75
Total Current Assets	782.13	440.99	232.24	129.63	191.3
Net Property, Plant & Equipment	24.31	15.33	18.21	17.9	11.82
Other Long-Term Assets	1.61	1.61	1.61	1.76	1.76
Total Assets	808.06	457.94	252.06	149.29	204.89
Accounts Payable	4.15	4.18	4.39	5.12	4.59
Accrued Expenses	43.84	35.12	28.67	24.1	20.12
Current Portion of Leases	2.82	1.93	1.59	1.6	1.62
Unearned Revenue	-	0.13	0.26	0.58	-
Total Current Liabilities	50.81	41.35	34.9	31.4	26.34
Long-Term Debt	71.34	68.51	74.93	54.01	51.44
Long-Term Leases	2.82	5.35	6.88	8.68	5.92
Other Long-Term Liabilities	28.79	27.39	44.23	19.83	33.19
Total Long-Term Liabilities	102.94	101.24	126.03	82.52	90.55
Total Liabilities	153.75	142.59	160.93	113.91	116.89
Common Stock	0.02	0.02	0.01	0.01	0.01
Additional Paid-in Capital	1,811	1,206	788.7	652.21	633.8
Retained Earnings	-1,157	-891.08	-697.58	-616.84	-545.8
Shareholders' Equity	654.31	315.34	91.13	35.38	88
Total Liabilities & Equity	808.06	457.94	252.06	149.29	204.89
Total Debt	76.97	75.78	83.39	64.28	58.98
Net Cash (Debt)	-76.97	-75.78	112.42	38.02	105.18
Net Cash Growth	-	-	195.70%	-63.86%	-37.99%
Net Cash Per Share	-0.41	-0.48	1.31	0.46	1.28
Book Value	654.31	315.34	91.13	35.38	88
Book Value Per Share	3.49	1.99	1.06	0.43	1.07
Tangible Book Value	654.31	315.34	91.13	35.38	88
Tangible Book Value Per Share	3.49	1.99	1.06	0.43	1.07

Updated Feb 5, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q